recombinant growth hormone somatropin
Selected indexed studies
- Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study. (J Clin Endocrinol Metab, 2022) [PMID:35405011]
- Safety and Efficacy of Pediatric Growth Hormone Therapy: Results From the Full KIGS Cohort. (J Clin Endocrinol Metab, 2022) [PMID:36102184]
- Growth hormone - past, present and future. (Nat Rev Endocrinol, 2018) [PMID:29546874]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study. (2022) pubmed
- Safety and Efficacy of Pediatric Growth Hormone Therapy: Results From the Full KIGS Cohort. (2022) pubmed
- Growth hormone - past, present and future. (2018) pubmed
- Growth hormone. (2010) pubmed
- Somatropin therapy in italian adults with growth hormone deficiency. (2022) pubmed
- Recombinant growth hormone therapy for X-linked hypophosphatemia in children. (2021) pubmed
- The use of somatropin (recombinant growth hormone) in children of short stature. (2002) pubmed
- Recombinant growth hormone improves growth and adult height in patients with maternal inactivating GNAS mutations. (2023) pubmed
- Outcomes of recombinant growth hormone therapy in the traumatic brain injury population: A scoping review. (2025) pubmed
- [Somatropin and final height in Mexican paediatric population with growth hormone deficiency]. (2022) pubmed